QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors

European Journal of Medicinal Chemistry
2010.0

Abstract

We performed a predictive analysis based on Quantitative Structure-Activity Relationships (QSAR) of a very important property of flavonoids which is the inhibition (IC50) of influenza H1N1 virus neuraminidase. The best linear model constructed from 20 molecular structures incorporated four molecular descriptors, selected from more than a thousand geometrical, topological, quantum-mechanical and electronic types of descriptors. The obtained model suggests that the activity depends on the electric charges, masses and polarizabilities of the atoms present in the molecule as well as its conformation. The model showed good predictive ability established by the theoretical and external test set validations.

Knowledge Graph

Similar Paper

QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors
European Journal of Medicinal Chemistry 2010.0
QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network
European Journal of Medicinal Chemistry 2008.0
Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities
Bioorganic & Medicinal Chemistry 2008.0
Comparative Binding Energy (COMBINE) Analysis of Influenza Neuraminidase−Inhibitor Complexes
Journal of Medicinal Chemistry 2001.0
Quantitative structure activity relationship (QSAR) of piperine analogsfor bacterial NorA efflux pump inhibitors
European Journal of Medicinal Chemistry 2009.0
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase
Bioorganic & Medicinal Chemistry Letters 2014.0
Quantitative structure–activity relationship (QSAR) of aryl alkenyl amides/imines for bacterial efflux pump inhibitors
European Journal of Medicinal Chemistry 2009.0
Design, synthesis and exploring the quantitative structure–activity relationship of some antioxidant flavonoid analogues
Bioorganic & Medicinal Chemistry Letters 2014.0
Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors
Bioorganic & Medicinal Chemistry Letters 2017.0
Quantitative Structure−Activity Relationship Studies of [(Biphenyloxy)propyl]isoxazole Derivatives. Inhibitors of Human Rhinovirus 2 Replication
Journal of Medicinal Chemistry 2007.0